US asthma guidelines stress early steroid useBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7081.623k (Published 01 March 1997) Cite this as: BMJ 1997;314:623
- Jenny Bryan
Newly updated guidelines on the management of asthma, released this week by the United States National Institutes of Health, emphasise the need for early use of anti-inflammatory drugs–in line with recommendations in the revised British Thoracic Society's guidelines (1 February, p 315-6).
The US version, however, uses a four step classification for asthma severity–mild intermittent, mild persistent, moderate persistent, and severe persistent–and recommends starting inhaled corticosteroids, cromoglycate, or nedocromil at the mild persistent stage.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial